In this issue:

  • Iron deficiency in HF
  • Contemporary SGLT-2 inhibitor use in HF patients with diabetes
  • Primary care HF service for identifying missed diagnoses of HFREF
  • Renal dysfunction’s impact on cardiac outcomes and end-stage renal disease in HF with mitral regurgitation
  • Weekend vs. weekday admissions for HF, with/without AF
  • Long-term survival and life expectancy following acute HF hospitalisation
  • Efficacy and safety of dapagliflozin in HF according to frailty
  • Iron deficiency and anaemia in ambulatory chronic HF patients

Download Heart Failure Research Review, Issue 72, with commentary by Prof Andrew Coats